In C57BL/6 mice implanted with murine glioma cell line GL261-luc2, the use of combination treatment such as radiotherapy, anti-PD-1 and anti-TIM3 has been shown to be synergistic and improve survival above dual therapy [137]. Here, HAVCR2 is linked to glioma.